-
Something wrong with this record ?
Identification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approach
T. Uher, M. Vaneckova, MP. Sormani, J. Krasensky, L. Sobisek, JB. Dusankova, Z. Seidl, E. Havrdova, T. Kalincik, RH. Benedict, D. Horakova,
Language English Country Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
NT13237
MZ0
CEP Register
PubMed
27873386
DOI
10.1111/ene.13200
Knihovny.cz E-resources
- MeSH
- Atrophy diagnostic imaging pathology MeSH
- Adult MeSH
- Cognitive Dysfunction diagnostic imaging pathology psychology MeSH
- Middle Aged MeSH
- Humans MeSH
- Magnetic Resonance Imaging methods MeSH
- Brain diagnostic imaging pathology MeSH
- Neuropsychological Tests MeSH
- Multiple Sclerosis diagnostic imaging pathology psychology MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
BACKGROUND AND PURPOSE: While impaired cognitive performance is common in multiple sclerosis (MS), it has been largely underdiagnosed. Here a magnetic resonance imaging (MRI) screening algorithm is proposed to identify patients at highest risk of cognitive impairment. The objective was to examine whether assessment of lesion burden together with whole brain atrophy on MRI improves our ability to identify cognitively impaired MS patients. METHODS: Of the 1253 patients enrolled in the study, 1052 patients with all cognitive, volumetric MRI and clinical data available were included in the analysis. Brain MRI and neuropsychological assessment with the Brief International Cognitive Assessment for Multiple Sclerosis were performed. Multivariable logistic regression and individual prediction analysis were used to investigate the associations between MRI markers and cognitive impairment. The results of the primary analysis were validated at two subsequent time points (months 12 and 24). RESULTS: The prevalence of cognitive impairment was greater in patients with low brain parenchymal fraction (BPF) (<0.85) and high T2 lesion volume (T2-LV) (>3.5 ml) than in patients with high BPF (>0.85) and low T2-LV (<3.5 ml), with an odds ratio (OR) of 6.5 (95% CI 4.4-9.5). Low BPF together with high T2-LV identified in 270 (25.7%) patients predicted cognitive impairment with 83% specificity, 82% negative predictive value, 51% sensitivity and 75% overall accuracy. The risk of confirmed cognitive decline over the follow-up was greater in patients with high T2-LV (OR 2.1; 95% CI 1.1-3.8) and low BPF (OR 2.6; 95% CI 1.4-4.7). CONCLUSIONS: The integrated MRI assessment of lesion burden and brain atrophy may improve the stratification of MS patients who may benefit from cognitive assessment.
Department of Health Sciences University of Genoa Genoa Italy
Department of Statistics and Probability University of Economics Prague Prague Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18016902
- 003
- CZ-PrNML
- 005
- 20181023155840.0
- 007
- ta
- 008
- 180515s2017 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/ene.13200 $2 doi
- 035 __
- $a (PubMed)27873386
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Uher, Tomáš $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic. $7 xx0189534
- 245 10
- $a Identification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approach / $c T. Uher, M. Vaneckova, MP. Sormani, J. Krasensky, L. Sobisek, JB. Dusankova, Z. Seidl, E. Havrdova, T. Kalincik, RH. Benedict, D. Horakova,
- 520 9_
- $a BACKGROUND AND PURPOSE: While impaired cognitive performance is common in multiple sclerosis (MS), it has been largely underdiagnosed. Here a magnetic resonance imaging (MRI) screening algorithm is proposed to identify patients at highest risk of cognitive impairment. The objective was to examine whether assessment of lesion burden together with whole brain atrophy on MRI improves our ability to identify cognitively impaired MS patients. METHODS: Of the 1253 patients enrolled in the study, 1052 patients with all cognitive, volumetric MRI and clinical data available were included in the analysis. Brain MRI and neuropsychological assessment with the Brief International Cognitive Assessment for Multiple Sclerosis were performed. Multivariable logistic regression and individual prediction analysis were used to investigate the associations between MRI markers and cognitive impairment. The results of the primary analysis were validated at two subsequent time points (months 12 and 24). RESULTS: The prevalence of cognitive impairment was greater in patients with low brain parenchymal fraction (BPF) (<0.85) and high T2 lesion volume (T2-LV) (>3.5 ml) than in patients with high BPF (>0.85) and low T2-LV (<3.5 ml), with an odds ratio (OR) of 6.5 (95% CI 4.4-9.5). Low BPF together with high T2-LV identified in 270 (25.7%) patients predicted cognitive impairment with 83% specificity, 82% negative predictive value, 51% sensitivity and 75% overall accuracy. The risk of confirmed cognitive decline over the follow-up was greater in patients with high T2-LV (OR 2.1; 95% CI 1.1-3.8) and low BPF (OR 2.6; 95% CI 1.4-4.7). CONCLUSIONS: The integrated MRI assessment of lesion burden and brain atrophy may improve the stratification of MS patients who may benefit from cognitive assessment.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a atrofie $x diagnostické zobrazování $x patologie $7 D001284
- 650 _2
- $a mozek $x diagnostické zobrazování $x patologie $7 D001921
- 650 _2
- $a kognitivní dysfunkce $x diagnostické zobrazování $x patologie $x psychologie $7 D060825
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a magnetická rezonanční tomografie $x metody $7 D008279
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a roztroušená skleróza $x diagnostické zobrazování $x patologie $x psychologie $7 D009103
- 650 _2
- $a neuropsychologické testy $7 D009483
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Vaněčková, Manuela, $u Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic. $d 1973- $7 mzk2007377403
- 700 1_
- $a Sormani, M P $u Department of Health Sciences, University of Genoa, Genoa, Italy.
- 700 1_
- $a Krásenský, Jan $u Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic. $7 xx0096156
- 700 1_
- $a Sobíšek, Lukáš. $u Department of Statistics and Probability, University of Economics in Prague, Prague, Czech Republic. $7 xx0238269
- 700 1_
- $a Blahová Dušánková, Jana $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic. $7 jx20070410009
- 700 1_
- $a Seidl, Zdeněk, $u Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic. $d 1950- $7 mzk2004258727
- 700 1_
- $a Kubala Havrdová, Eva, $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic. $d 1955- $7 nlk19990073204
- 700 1_
- $a Kalincik, T $u Department of Medicine, University of Melbourne, Melbourne, Vic., Australia. Department of Neurology, Royal Melbourne Hospital, Melbourne, Vic., Australia.
- 700 1_
- $a Benedict, R H B $u Department of Neurology, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA.
- 700 1_
- $a Horáková, Dana $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic. $7 xx0076527
- 773 0_
- $w MED00001629 $t European journal of neurology $x 1468-1331 $g Roč. 24, č. 2 (2017), s. 292-301
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27873386 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180515 $b ABA008
- 991 __
- $a 20181023160347 $b ABA008
- 999 __
- $a ok $b bmc $g 1300526 $s 1013742
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 24 $c 2 $d 292-301 $e 20161122 $i 1468-1331 $m European journal of neurology $n Eur J Neurol $x MED00001629
- GRA __
- $a NT13237 $p MZ0
- LZP __
- $a Pubmed-20180515